These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1696507)

  • 41. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
    Wallach D
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.
    Gardner LJ; Vilcek J
    J Gen Virol; 1979 Jul; 44(1):161-8. PubMed ID: 227987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monkey interferon: activity on human cells and chromatographic properties. Brief report.
    Yakobson E; Revel M; Gurari-Rotman D
    Arch Virol; 1979; 59(3):251-5. PubMed ID: 222238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.
    Singh N; Ramĩrez-Carvajal L; de Los Santos T; Golding MC; Long CR
    J Interferon Cytokine Res; 2016 Jan; 36(1):37-47. PubMed ID: 26418342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP.
    Chen W; Wen Z; Zhang J; Li C; Huang K; Bu Z
    J Virol Methods; 2018 Feb; 252():1-7. PubMed ID: 28834736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further studies on the relative antiviral efficacies of interferons induced by poly I:C and Mengo virus.
    Campbell JB
    Can J Microbiol; 1976 May; 22(5):712-8. PubMed ID: 179687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
    Auclair C; Dugué B; Meunier B; Paoletti C
    Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of increasing 2'-O-methylation on the interferon stimulating capacity of poly(rl)-poly(rC).
    Merigan TC; Rottman F
    Virology; 1974 Jul; 60(1):297-301. PubMed ID: 4366498
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition.
    Le Mée S; Pierré A; Markovits J; Atassi G; Jacquemin-Sablon A; Saucier JM
    Mol Pharmacol; 1998 Feb; 53(2):213-20. PubMed ID: 9463478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of oxygen on the antiviral activity of human interferon in cell culture].
    Krivokhatskaia LD; Povolotskiĭ IaL; Spivak NIa
    Antibiotiki; 1980 Jun; 25(6):464-6. PubMed ID: 6156641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pegylation of IFN-alpha and antiviral activity.
    Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
    J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Proteins induced by various types of double-stranded RNA and interferon type I in human fibroblasts. Correlation with antiviral activity of the substances].
    Sokolova TM; Antonov AIu; Suetina IA
    Antibiot Khimioter; 1992 May; 37(5):24-7. PubMed ID: 1329688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages.
    Di Marzio P; Gessani S; Locardi C; Borghi P; Baglioni C; Belardelli F
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2585-91. PubMed ID: 1701475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pleiotropic activities of human interferons are mediated by multiple response pathways.
    Forti RL; Mitchell WM; Hubbard WC; Workman RJ; Forbes JT
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):170-4. PubMed ID: 6320163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.